These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28042312)

  • 1. Antitumor therapeutic application of self-assembled RNAi-AuNP nanoconstructs: Combination of VEGF-RNAi and photothermal ablation.
    Son S; Kim N; You DG; Yoon HY; Yhee JY; Kim K; Kwon IC; Kim SH
    Theranostics; 2017; 7(1):9-22. PubMed ID: 28042312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of Graphene and AuNP Core Polyaniline Shell Nanocomposites as Multifunctional Theranostic Platforms for SERS Real-time Monitoring and Chemo-photothermal Therapy.
    Chen H; Liu Z; Li S; Su C; Qiu X; Zhong H; Guo Z
    Theranostics; 2016; 6(8):1096-104. PubMed ID: 27279904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
    J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic anticancer effect of RNAi and photothermal therapy mediated by functionalized single-walled carbon nanotubes.
    Wang L; Shi J; Zhang H; Li H; Gao Y; Wang Z; Wang H; Li L; Zhang C; Chen C; Zhang Z; Zhang Y
    Biomaterials; 2013 Jan; 34(1):262-74. PubMed ID: 23046752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photothermal therapeutic response of cancer cells to aptamer-gold nanoparticle-hybridized graphene oxide under NIR illumination.
    Yang L; Tseng YT; Suo G; Chen L; Yu J; Chiu WJ; Huang CC; Lin CH
    ACS Appl Mater Interfaces; 2015 Mar; 7(9):5097-106. PubMed ID: 25705789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics.
    Takei Y; Kadomatsu K; Yuzawa Y; Matsuo S; Muramatsu T
    Cancer Res; 2004 May; 64(10):3365-70. PubMed ID: 15150085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision combination therapy for triple negative breast cancer via biomimetic polydopamine polymer core-shell nanostructures.
    Ding Y; Su S; Zhang R; Shao L; Zhang Y; Wang B; Li Y; Chen L; Yu Q; Wu Y; Nie G
    Biomaterials; 2017 Jan; 113():243-252. PubMed ID: 27829203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-crosslinked human serum albumin nanocarriers for systemic delivery of polymerized siRNA to tumors.
    Son S; Song S; Lee SJ; Min S; Kim SA; Yhee JY; Huh MS; Chan Kwon I; Jeong SY; Byun Y; Kim SH; Kim K
    Biomaterials; 2013 Dec; 34(37):9475-85. PubMed ID: 24050874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis.
    Ding Y; Wang Y; Zhou J; Gu X; Wang W; Liu C; Bao X; Wang C; Li Y; Zhang Q
    Biomaterials; 2014 Aug; 35(25):7214-27. PubMed ID: 24875759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule inhibition of proteasome and silencing by vascular endothelial cell growth factor-specific siRNA induce additive antitumor activity in multiple myeloma.
    Koldehoff M; Beelen DW; Elmaagacli AH
    J Leukoc Biol; 2008 Aug; 84(2):561-76. PubMed ID: 18458152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of VEGF and Bcl-2 dual-targeted siRNA polymer using a single nanoparticle for synergistic anti-cancer effects in vivo.
    Lee SJ; Yook S; Yhee JY; Yoon HY; Kim MG; Ku SH; Kim SH; Park JH; Jeong JH; Kwon IC; Lee S; Lee H; Kim K
    J Control Release; 2015 Dec; 220(Pt B):631-41. PubMed ID: 26307351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Captopril-polyethyleneimine conjugate modified gold nanoparticles for co-delivery of drug and gene in anti-angiogenesis breast cancer therapy.
    Li M; Li Y; Huang X; Lu X
    J Biomater Sci Polym Ed; 2015; 26(13):813-27. PubMed ID: 26166244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High efficacy gold-KDEL peptide-siRNA nanoconstruct-mediated transfection in C2C12 myoblasts and myotubes.
    Acharya S; Hill RA
    Nanomedicine; 2014 Feb; 10(2):329-37. PubMed ID: 23928216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-angiogenic efficacy of 5'-triphosphate siRNA combining VEGF silencing and RIG-I activation in NSCLCs.
    Yuan D; Xia M; Meng G; Xu C; Song Y; Wei J
    Oncotarget; 2015 Oct; 6(30):29664-74. PubMed ID: 26336994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined cancer photothermal-chemotherapy based on doxorubicin/gold nanorod-loaded polymersomes.
    Liao J; Li W; Peng J; Yang Q; Li H; Wei Y; Zhang X; Qian Z
    Theranostics; 2015; 5(4):345-56. PubMed ID: 25699095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
    Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
    Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy.
    Kim SH; Jeong JH; Lee SH; Kim SW; Park TG
    J Control Release; 2006 Nov; 116(2):123-9. PubMed ID: 16831481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-Assembled Nanoconstructs Modified with Amplified Aptamers Inhibited Tumor Growth and Retinal Vascular Hyperpermeability via Vascular Endothelial Growth Factor Capturing.
    Lee J; Lee BJ; Lee YM; Park H; Kim JH; Kim WJ
    Mol Pharm; 2017 May; 14(5):1460-1468. PubMed ID: 28191845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy.
    Ahmed M; Kumar G; Navarro G; Wang Y; Gourevitch S; Moussa MH; Rozenblum N; Levchenko T; Galun E; Torchilin VP; Goldberg SN
    PLoS One; 2015; 10(7):e0128910. PubMed ID: 26154425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the therapeutic efficacy of codelivery of psiRNA-vascular endothelial growth factor and pIL-4 into chitosan nanoparticles in the breast tumor model.
    Şalva E; Turan SO; Kabasakal L; Alan S; Özkan N; Eren F; Akbuğa J
    J Pharm Sci; 2014 Mar; 103(3):785-95. PubMed ID: 24357345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.